Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2025-12-24 @ 9:43 PM
NCT ID:
NCT00704132
Eligibility Criteria:
Inclusion Criteria:
* Participant has type 2 diabetes mellitus
* Males
* Females who are highly unlikely to become pregnant
* Participants poorly controlled without taking any, or taking one or two oral antidiabetic medications
Exclusion Criteria:
* Participant has a history of type 1 diabetes mellitus or history of ketoacidosis
* Participant required insulin therapy within the prior 8 weeks
* Participant is on or has been taking TZDs such as Actos® (pioglitazone) or Avandia® (rosiglitazone) within the prior 12 weeks of the screening visit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
70 Years
Study:
NCT00704132
Study Brief:
Protocol Section:
NCT00704132